论文部分内容阅读
目的观察肌氨肽苷治疗急性脑梗死的疗效。方法选择金水区总医院住院的有肢体运动、感觉、语言、意识障碍、CT或MRI显示有相应病灶的急性脑梗塞患者61例,发病均在7d内。随机分为2组。治疗组采用肌氨肽苷注射液(利欣,2ml/支)8ml加入0.9%氯化钠注射液250ml,1天1次,静脉注射,疗程2周,两组的其他常规用药相同,均给予血栓通粉针0.5加入0.9%氯化钠250ml静脉滴注,每日1次;吡拉西坦注射液100ml静脉滴注,每日1次,疗程2周,依达拉奉针加入0.9%氯化钠100ml静脉滴注,每日2次。结果治疗前后两组神经功能缺失积分减少程度比较有显著性差异(P<0.05),两组总有效率分别为治疗组87.10%;对照组73.3%。两组经Ridit分析有显著差异性(P<0.05)。结论肌氨肽苷治疗急性脑梗死有较好的疗效及安全性。
Objective To observe the therapeutic effect of muscle aminopeptidase on acute cerebral infarction. Methods Sixty - one acute cerebral infarction patients with limb movement, sensory, language and disturbance of consciousness who were diagnosed by CT or MRI were selected. Randomly divided into two groups. The treatment group using muscle aminopeptidase injection (Lixin, 2ml / branch) 8ml 0.9% sodium chloride injection 250ml, 1 day, intravenous injection, the course of 2 weeks, the other two groups of the same conventional medication, are given Thrombus needles 0.5 0.5% 0.9% sodium chloride 250ml intravenous infusion, once daily; Piracetam injection 100ml intravenous infusion, once daily for 2 weeks, edaravone needle by adding 0.9% chlorine Sodium 100ml intravenous infusion, 2 times a day. Results Before and after treatment, there was a significant difference in the reduction of neurological deficit scores between the two groups (P <0.05). The total effective rate was 87.10% in the treatment group and 73.3% in the control group. Ridit analysis showed significant differences between the two groups (P <0.05). Conclusion Aminopeptidyl glycosides in the treatment of acute cerebral infarction have a good effect and safety.